Jeffrey S. Price
Amministratore Delegato presso Octamer, Inc.
Profilo
Jeffrey S.
Price is currently the Chief Executive Officer, CFO & Director at Octamer, Inc. and the Chairman at Planet Biotechnology, Inc. He previously served as the Director-Supervisory Board at PanGenetics BV and as the Senior Vice President-Research & Development at Cetus Corp.
Posizioni attive di Jeffrey S. Price
| Società | Posizione | Inizio |
|---|---|---|
Octamer, Inc.
 Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Amministratore Delegato | - |
Planet Biotechnology, Inc.
 Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Presidente | 01/01/1998 |
Precedenti posizioni note di Jeffrey S. Price
| Società | Posizione | Fine |
|---|---|---|
| Cetus Corp. | Direttore Tecnico/Scientifico/R&S | - |
PanGenetics BV
 PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Planet Biotechnology, Inc.
Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Health Technology |
PanGenetics BV
PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
| Cetus Corp. | Health Technology |
Octamer, Inc.
Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey S. Price
